Clinical Trials Browser

Interventional × Rituximab × Other solid neoplasm × Clear all

NCT04375228 2026-02-06

Study of Rituximab or Tocilizumab for Patients With Steroid-Dependent Immune-Related Adverse Events (irAEs)

Phase 2 Active not recruiting

Other solid neoplasm

Immune-related Adverse Events

NCT05279300 2025-08-11

A Study of CS5001 in Patients With Advanced Solid Tumors and Lymphomas

Phase 1 Recruiting

LymphoidOther solid neoplasm

Advanced Solid Tumor